EUVIMEDEUVIMED entdecken
Crossref

Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment

YuTing Ji, Hong Yang

Biomedical Engineering Communications · 2022

DOI: 10.53388/bmec2022006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2022. Verfasst von YuTing Ji und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ji, Y., & Yang, H. (2022). Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment. Biomedical Engineering Communications. https://doi.org/10.53388/bmec2022006

Vancouver

Ji Y, Yang H. Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment. Biomedical Engineering Communications. 2022. doi:10.53388/bmec2022006

BibTeX
@article{Ji2022,
  author = {Ji, YuTing and Yang, Hong},
  title = {Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment},
  journal = {Biomedical Engineering Communications},
  year = {2022},
  doi = {10.53388/bmec2022006}
}
Kostenlos starten →